I. Jollet

发表

HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.

D. Blaise, A. Moine, A. Toubert, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

M. Metzger, G. Choukroun, N. Kamar, 2019, Kidney international.

Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI

T. Cluzeau, B. Mercier, D. Charron, 2016, Bone Marrow Transplantation.

Identification of a novel HLA allele, HLA-B*53:39, in a Guadaloupean individual.

C. Giraud, I. Jollet, D. Masson, 2015, Tissue antigens.

Improvement in HLA‐typing by new sequence‐specific oligonucleotides kits for HLA‐A, ‐B, and ‐DRB1 loci

I. Jollet, G. Guidicelli, J. Visentin, 2018, HLA.

Long-term follow-up of corticosteroid refractory acute GVHD treated with an Inolimomab-based algorithm: a single center experience

F. Guilhot, J. Guilhot, I. Jollet, 2013, Bone Marrow Transplantation.

Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post-transplantation.

P. Gatault, Y. Lebranchu, C. Baron, 2011, Tissue antigens.

Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d’Histocompatibilité et d’Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (

D. Hanau, E. Masson, D. Charron, 2013, Haematologica.

Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.

A. Vernallis, J. Taupin, F. Blanchard, 1997, Journal of immunological methods.

Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study

I. Yakoub-Agha, J. Eliaou, D. Hanau, 2015, Bone Marrow Transplantation.

Erratum to “Very low residual concentrations of rituximab long after infusion still induce positive B-cell complement-dependent cytotoxicity-crossmatch” [Hum. Immunol. 74 (2013) 1616–1618]

P. Gatault, Y. Lebranchu, M. Büchler, 2014 .

Abolishing serum interference in detection of HLA antibodies: Who, How, When and Why?

N. Valenzuela, J. Taupin, I. Jollet, 2019, Human immunology.

HLA graph, a free and ready‐to‐use bioinformatics tool to explore anti‐HLA eplets reactivity pattern

V. Dubois, J. Taupin, J. Desoutter, 2022, HLA.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

D. Blaise, A. Moine, M. Busson, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.

A. Moine, M. Busson, D. Charron, 2007, Tissue antigens.

Donor‐targeted serotherapy as a rescue therapy for steroid‐resistant acute GVHD after HLA‐mismatched kidney transplantation

R. Salomon, P. Tiberghien, B. Neven, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

HLA‐DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation

R. Porcher, P. van Endert, P. Chevallier, 2018, American journal of hematology.

Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.

J. Coindre, G. MacGrogan, V. Picot, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Monoclonal secondary reagents do not outperform polyclonal secondary reagents for detection of anti‐HLA IgG using single antigen flow beads assays

S. Caillat-Zucman, I. Jollet, J. Visentin, 2020, HLA.